로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > RNF43

RNF43

요약

Name:E3 ubiquitin-protein ligase RNF43
Target Synonym:
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
태그별:
결합물별:
제품번호 제품 설명 구조 순도 특징
RN3-H5256 Human Human RNF43 Protein, Fc Tag (MALS verified)
RN3-H5256-structure
RN3-H5256-sds

일부의 생물활성 데이터

RN3-H5256-MALS-HPLC
RNF43 MALS images

The purity of Human RNF43, Fc Tag (Cat. No. RN3-H5256) is more than 85% and the molecular weight of this protein is around 100-115 kDa verified by SEC-MALS.

RN3-H5256-ELISA
 RNF43 ELISA

Immobilized Human R-Spondin 1, His Tag (Cat. No. RS1-H4221) at 5 μg/mL (100 μL/well) can bind Human RNF43, Fc Tag (Cat. No. RN3-H5256) with a linear range of 2-20 ng/mL (QC tested).

Synonym Name

RING finger protein 43,RING-type E3 ubiquitin transferase RNF43

Background

E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the ubiquitination, endocytosis and subsequent degradation of Wnt receptor complex components Frizzled. Acts on both canonical and non-canonical Wnt signaling pathway. Along with RSPO2 and ZNRF3, constitutes a master switch that governs limb specification (By similarity)

Clinical and Translational Updates

    임상 약품 정보

    Name Research Code Research Phase Company Indications Clinical Trials
    SZN-043 SZN-043; SZN-043双特异性融合蛋白; SZN-043 Bispecific Fusion Protein; SZN-043 (RSPO模拟物) Phase 1 Clinical Surrozen Inc Hepatitis, Alcoholic; Liver Cirrhosis Details
    SZN-043 SZN-043; SZN-043双特异性融合蛋白; SZN-043 Bispecific Fusion Protein; SZN-043 (RSPO模拟物) Phase 1 Clinical Surrozen Inc Hepatitis, Alcoholic; Liver Cirrhosis Details

    This web search service is supported by Google Inc.

    totop